Egerton Capital (UK)’s Praxair Inc PX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-3,493,722
Closed -$562M 32
2018
Q3
$562M Sell
3,493,722
-783,760
-18% -$126M 4.17% 11
2018
Q2
$676M Sell
4,277,482
-20,965
-0.5% -$3.24M 5.17% 3
2018
Q1
$620M Buy
4,298,447
+84,471
+2% +$13.1M 5.05% 6
2017
Q4
$652M Buy
4,213,976
+829,003
+24% +$123M 5.71% 4
2017
Q3
$473M Buy
3,384,973
+655,456
+24% +$87.4M 4.23% 9
2017
Q2
$362M Buy
2,729,517
+391,430
+17% +$50.2M 3.63% 12
2017
Q1
$277M Buy
2,338,087
+215,399
+10% +$25.3M 3% 16
2016
Q4
$249M Buy
2,122,688
+1,322,051
+165% +$157M 3.02% 14
2016
Q3
$96.7M Buy
+800,637
New +$94.8M 1.1% 23

Other funds holding PX

Egerton Capital (UK)'s PX Position: Q4 2018 in Review

Egerton Capital (UK) sold out of Praxair Inc (PX) in Q4 2018, closing a stake of 3,493,722 shares — an estimated $562M sold.

Egerton Capital (UK) first reported a position in PX in Q3 2016 and held it in 9 quarters. The position peaked at $676M in Q2 2018. 6 funds tracked by Wall St. Rank hold PX as of Q4 2018.

  • Egerton Capital (UK) reported no remaining Praxair Inc position as of Q4 2018 after selling out during the quarter.
  • Egerton Capital (UK) sold 3,493,722 Praxair Inc shares in Q4 2018, an estimated $562M.
  • Egerton Capital (UK) first reported a position in Praxair Inc in Q3 2016 and held it in 9 quarters.
  • Egerton Capital (UK)'s Praxair Inc position peaked at $676M in Q2 2018.
  • 6 funds tracked by Wall St. Rank held Praxair Inc as of Q4 2018.

Based on Egerton Capital (UK)'s 13F filing for Q4 2018, filed 12 Feb 2019.